Physician profile
Amina Farooq
NPI 1821520131
$1,913.66
in general payments reported to CMS, 2019-2025
7 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $247 · 2023: $29.60 · 2024: $1,373 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $836 · Travel and Lodging: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.17 |
| Travel and Lodging | $830.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,084.21 | 2024 | Gore Viatorr Tips Endoprosthesis, Viatorr Tips Endoprosthesis W/ Controlled Expansion, Viatorr Endoprosthesis |
| Boston Scientific Corporation | $340.25 | 2024-2025 | General - Interventional Oncology, Therasphere Y90 Glass Microspheres 10 Gbq, Spyglass Discover |
| Inari Medical, INC. | $247.08 | 2022 | |
| Becton, Dickinson and Company | $134.48 | 2025 | Lutonix Drug Coated Balloon, Trek |
| Medtronic, INC. | $49.43 | 2024 | Kyphon Express II Kyphopak Tray |
| Terumo Medical Corporation | $29.60 | 2023 | Navicross, Tr Band, Glidewire |
| Sirtex Medical INC | $28.61 | 2024 | Lava Les (Liquid Embolic System) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amina Farooq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.